(Q42815399)

7 November 2017

title

A novel peroxisome proliferator-activated receptor gamma isoform with dominant negative activity generated by alternative splicing (English)

1 reference

alternative mRNA splicing, via spliceosome

7 November 2017

main subject

1 reference

1

1 reference

7 November 2017

2

Amelia Casamassimi

1 reference

7 November 2017

7

Patrizia Bonelli

1 reference

7 November 2017

Gianfranco Peluso

3

1 reference

7 November 2017

Maria Vittoria Barone

4

1 reference

7 November 2017

Daniela Capaccio

5

1 reference

7 November 2017

Chiara Migliore

6

1 reference

7 November 2017

Antonio Pedicini

8

1 reference

7 November 2017

Antonio Febbraro

9

1 reference

7 November 2017

Alfredo Ciccodicola

10

1 reference

7 November 2017

Vittorio Colantuoni

11

1 reference

7 November 2017

language of work or name

English

0 references

publication date

27 April 2005

1 reference

Journal of Biological Chemistry

7 November 2017

published in

1 reference

7 November 2017

volume

280

1 reference

7 November 2017

issue

28

1 reference

7 November 2017

page(s)

26517-26525

1 reference

Nuclear receptors and the control of metabolism

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Molecular characterisation of six alternatively spliced variants and a novel promoter in human peroxisome proliferator-activated receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Expression of solute carrier 7A4 (SLC7A4) in the plasma membrane is not sufficient to mediate amino acid transport activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Genetic deficiency in Pparg does not alter development of experimental prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

PPAR gamma signaling exacerbates mammary gland tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Mechanisms of alternative pre-messenger RNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Alternative pre-mRNA splicing and proteome expansion in metazoans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Modulation of mammalian life span by the short isoform of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Alternative splicing and mutation status of CHEK2 in stage III breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Lessons from hereditary colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

APC-dependent suppression of colon carcinogenesis by PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

c-MYC: more than just a matter of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

A Truncated Human Peroxisome Proliferator-Activated Receptor Splice Variant with Dominant Negative Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502716200

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

15 July 2023

Identifiers

DOI

10.1074/JBC.M502716200

1 reference

7 November 2017

1 reference